𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Organ preservation for advanced laryngeal carcinoma

✍ Scribed by Robert L. Foote; R. Tyler Foote; Paul D. Brown; Yolanda I. Garces; Scott H. Okuno; Scott E. Strome

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
146 KB
Volume
28
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

Inclusion of patients with mobile vocal cords on larynx preservation trials may lead to overstatement of larynx preservation (LPR) and survival (OS) rates.

Methods.

This is a retrospective review of patients at our institution who would have been eligible for the Department of Veterans Affairs Laryngeal Cancer Study Group (VA) and Radiation Therapy Oncology Group/Head and Neck Intergroup (RTOG 91‐11) clinical trials. No laryngeal conservation procedure could be performed in patients with mobile vocal cords.

Results.

One hundred one patients at our institution would have been eligible for the VA trial. The 2‐year OS was 76% for total laryngectomy and 90% for radiotherapy patients (p = .28) compared with 68% reported for the VA trial. Seventy‐three patients at our institution would have been eligible for the RTOG 91‐11 trial. The 5‐year OS was 52% for total laryngectomy and 63% for radiotherapy patients (p = .18) compared with 55% reported for the RTOG 91‐11 trial. Radiotherapy patients had an LPR of 80% (VA trial) and 86% (RTOG 91‐11 trial).

Conclusion.

It is unlikely that inclusion of patients with mobile vocal cords had a significant impact on OS or LPR for the VA and RTOG 91‐11 larynx preservation trials. Β© 2006 Wiley Periodicals, Inc. Head Neck, 2006

πŸ“œ SIMILAR VOLUMES

Chemotherapy alone for organ preservatio
Chemotherapy alone for organ preservation in advanced laryngeal cancer
✍ Vasu Divi; Francis P. Worden; Mark E. Prince; Avraham Eisbruch; Julia S. Lee; Ca πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 504 KB

Background. For patients with advanced laryngeal cancer, a trial was designed to determine if chemotherapy alone, in patients achieving a complete histologic complete response after a single neoadjuvant cycle, was an effective treatment with less morbidity than concurrent chemoradiotherapy. Methods

Induction chemotherapy for organ preserv
Induction chemotherapy for organ preservation in advanced laryngeal cancer: Is there a role?
✍ Dr. Gregory T. Wolf; Waun Ki Hong πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 523 KB

During the past 15 years, the accumulated experience in the use of induction or initial chemotherapy in patients with head and neck squamous cell carcinoma has led to new treatment strategies as alternatives to surgery in patients with advanced, previously untreated laryngeal cancer. These have been

Organ preservation surgery for laryngeal
Organ preservation surgery for laryngeal squamous cell carcinoma: Low incidence of thyroid cartilage invasion
✍ Dana M. Hartl; Guillaume Landry; StΓ©phane Hans; Patrick Marandas; Daniel F. Bras πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 87 KB

## Abstract ## Objectives/Hypothesis: Determine the incidence and risk factors for thyroid cartilage invasion in early and midstage laryngeal cancer. ## Study Design: Retrospective review. ## Methods: A retrospective review was carried out of tumors treated by open surgery with at least partia

Chemoselection as a strategy for organ p
Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion
✍ Francis P. Worden; Jeffrey Moyer; Julia S. Lee; Jeremy M. G. Taylor; Susan G. Ur πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 559 KB

## Abstract ## Objectives/Hypothesis: High rates of overall survival (OS) and laryngeal preservation were achieved in two sequential phase II clinical trials in patients with stage III/IV laryngeal squamous cell carcinoma (SCC). Patients were treated with chemoradiation after a >50% primary tumor